Stock listing
45E Stock Price, News, Filings & Events — Natera, Inc.
Selected listing: 45E · MUN · EUR · DE
This page tracks Natera, Inc.'s 45E:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 45E:MUN. 45E:MUN is the stock-level entry point for investors researching Natera, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 45E:MUN
- Asset type
- Stock
- Market cap
- $47.03B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- MUN
- Currency
- EUR
Natera, Inc. 45E:MUN stock context
This page tracks Natera, Inc.'s 45E:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 45E:MUN. 45E:MUN is the stock-level entry point for investors researching Natera, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Natera, Inc.
Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
August 28, 2026
Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
August 27, 2026
Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers
August 12, 2026
Natera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
August 5, 2026
Natera to Report its Second Quarter Results on August 6, 2026
July 30, 2026
Natera, Inc. earnings calls
Natera, Inc. (NTRA) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Natera, Inc. (NTRA) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Natera, Inc. (NTRA) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Natera, Inc. (NTRA) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Natera, Inc. (NTRA) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Natera, Inc. (NTRA) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Natera, Inc.
Natera, Inc. investor report
Review AI stock analysis and investor report context for 45E:MUN.
Natera, Inc. company profile
View the public company page for Natera, Inc. on 6ix.
Natera, Inc. news
Read company news and market updates connected to Natera, Inc..
Natera, Inc. investor events
Find investor webinars, events, and replay context for Natera, Inc..
Alternate listings
NTRA:NASDAQ
US · USD
Alternate listing for Natera, Inc.; the primary context on this page is 45E:MUN.
45E:GETTEX
DE · EUR
Alternate listing for Natera, Inc.; the primary context on this page is 45E:MUN.
45E:TRADEGATE
DE · EUR
Alternate listing for Natera, Inc.; the primary context on this page is 45E:MUN.
NTRA:BMV
MX · MXN
Alternate listing for Natera, Inc.; the primary context on this page is 45E:MUN.
NTRA:BIVA
MX · MXN
Alternate listing for Natera, Inc.; the primary context on this page is 45E:MUN.
NTRA:BOATS
US · USD
Alternate listing for Natera, Inc.; the primary context on this page is 45E:MUN.
NTRA:BX
CH · CHF
Alternate listing for Natera, Inc.; the primary context on this page is 45E:MUN.
45E:DUS
DE · EUR
Alternate listing for Natera, Inc.; the primary context on this page is 45E:MUN.
45E:FWB
DE · EUR
Alternate listing for Natera, Inc.; the primary context on this page is 45E:MUN.